Obesity Rx: How to Use New Medications in Cli...

Diabetes and obesity are on the rise, and there are new tools to help the prevention and management of this twin epidemic of "diabesity" in primary care. Drs Robert Kushner and Tim Garvey discuss. Relevant disclosures can be found with the episode show notes on Medscape (https:// ...  Show more

How do you medically evaluate a person who presents with obesity? Drs Robert Kushner and Amanda Velazquez share practical tools and pearls for community clinicians. Relevant disclosures can be found with the episode show notes on Medscape ( https://www.medscape.com/viewarticle/982 ...  Show more

New weight-loss drugs have transformed care for people with obesity. In this Clinical Reviews podcast, Robert F. Kushner, MD, MS, of Northwestern University Feinberg School of Medicine joins JAMA Deputy Editor Mary McGrae McDermott, MD, to discuss prescribing these drugs to im ...

New medications for obesity, such as semaglutide and tirzepatide, are highly effective but can be associated with adverse effects that reduce adherence. Obesity expert and author Robert Kushner, MD, joins JAMA Deputy Editor Mary McDermott, MD, to discuss a recent JAMA Insights ar ...  Show more

Join The Obesity Medicine Nutrition Course! Enter code POD15 at checkout for 15% off!

Anti-obesity medications are everywhere—but they also come with new challenges. From rapid weight loss and side effects to TikTok- ...

The rise in obesity and chronic disease over the years is alarming. Rather than genetics, it can be attributed to environmental and dietary changes, emphasizing the role of food quality over quantity. And while GLP-1 agonists like Ozempic may show some promise in addressing metab ...  Show more